Adam Bagg
Hospital of the University of Pennsylvania · 341 works · 22,819 citations · h-index 47
Top works
- Chimeric Antigen Receptor–Modified T Cells in Chronic Lymphoid Leukemia
- T Cells with Chimeric Antigen Receptors Have Potent Antitumor Effects and Can Establish Memory in Patients with Advanced Leukemia
- Chimeric antigen receptor T cells persist and induce sustained remissions in relapsed refractory chronic lymphocytic leukemia
- International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data
- Fatal systemic inflammatory response syndrome in a ornithine transcarbamylase deficient patient following adenoviral gene transfer
- Utility of FDG-PET scanning in lymphoma by WHO classification
- Cardiovascular toxicity and titin cross-reactivity of affinity-enhanced T cells in myeloma and melanoma
- International, evidence-based consensus diagnostic criteria for HHV-8–negative/idiopathic multicentric Castleman disease
- Survival of acute myeloid leukemia cells requires PI3 kinase activation
- Chimeric Antigen Receptor T Cells against CD19 for Multiple Myeloma
- Single-cell analysis of Hodgkin and Reed-Sternberg cells: molecular heterogeneity of gene expression and p53 mutations
- Myeloproliferative Disorders and Myelodysplastic Syndromes
- Bone marrow fibrosis: pathophysiology and clinical significance of increased bone marrow stromal fibres
- Atypical chronic myeloid leukemia is clinically distinct from unclassifiable myelodysplastic/myeloproliferative neoplasms
- Persistence of long-lived plasma cells and humoral immunity in individuals responding to CD19-directed CAR T-cell therapy
- Erythropoietin gene therapy leads to autoimmune anemia in macaques
- Chromosome 3q21 abnormalities associated with hyperactive thrombopoiesis in acute blastic transformation of chronic myeloid leukemia
- Genetic Inactivation of CD33 in Hematopoietic Stem Cells to Enable CAR T Cell Immunotherapy for Acute Myeloid Leukemia
- Guidance for Fluorescence in Situ Hybridization Testing in Hematologic Disorders
- In situ mantle cell lymphoma: clinical implications of an incidental finding with indolent clinical behavior